How to Start a Telemedicine Practice in Massachusetts (NP, PA and Physician Guide)

Yes: a nurse practitioner, physician assistant or physician can open a cash-pay telemedicine hormone practice in Massachusetts, and for experienced NPs it is one of the more workable states in the Northeast. The gating items are a Massachusetts license for anyone treating a patient located in Massachusetts (no telehealth registration, no physician compact yet), the two-year supervised-prescribing period before a newly certified NP practices independently, a state controlled-substances registration (MCSR) on top of the DEA number, mandatory electronic prescribing, and a laboratory framework that routes every test through a licensed practitioner’s order. This is a 2026 planning summary, not legal advice; confirm each point with the Massachusetts Board of Registration in Nursing, the Board of Registration in Medicine, the Board of Registration of Physician Assistants, the Department of Public Health and counsel, because rules change.

Massachusetts practice authority: who can run and own a telemedicine hormone practice

Nurse practitioners in Massachusetts

Massachusetts moved to full practice authority with Chapter 260 of the Acts of 2020, effective January 1, 2021. The operative language sits in M.G.L. c.112 §80E as amended (companion §80I lets an NP’s signature satisfy requirements that call for a physician’s). Under §80E a certified nurse practitioner may practice, including prescribing, without supervision after not less than two years of supervised practice following certification by a board-recognized certifying body; the statute also lets the Board recognize at least two years of qualifying alternative experience, which is how NPs arriving from other full-practice states expect to qualify. The Board of Registration in Nursing implemented this through 244 CMR 4.00, updated in September 2021.

The detail that matters for a new hormone practice is what the first two years look like. An NP in the supervised period prescribes under written, mutually agreed guidelines with a “qualified healthcare professional”: a physician with an unrestricted Massachusetts license, relevant board certification or admitting privileges and a controlled-substance registration, or another APRN in the same category with several years of prescribing experience. The guidelines stay at the practice rather than being filed with the state, must be produced on request, and are commonly summarized as requiring review of an initial Schedule II prescription within 96 hours and re-execution every two years. Supervision applies to prescriptive practice, not to forming the business, and an NP who clears the two-year mark applies to the Board for authorization to prescribe without supervision. Read the current 244 CMR 4.07 with your qualified healthcare professional before signing.

Prescribing runs through two registrations: a DEA number and a Massachusetts Controlled Substances Registration (MCSR) from the Department of Public Health’s Drug Control Program, with matching schedules. Testosterone is Schedule III federally and within an NP’s authority in Massachusetts as commonly read; check the Board’s prescribing guidance for anything new.

Physician assistants in Massachusetts

PAs are licensed by the Board of Registration of Physician Assistants and practice under a supervising physician with a full, unrestricted Massachusetts license. Massachusetts removed the numeric cap on PAs per physician in 2012 (M.G.L. c.112 §9E), so there is no ratio to manage, but supervision must be adequate to the setting (physical presence is not required), and 263 CMR 5.00 says a PA may not supplant the physician as principal medical decision-maker or be the sole clinician in an outpatient service where a physician is not regularly available. Prescribing follows written guidelines signed by the PA and supervising physician and reviewed annually; any Schedule II prescription must be reviewed by the physician within 96 hours, and 243 CMR 2.08 has the physician review the PA’s prescribing at least every three months. A PA needs both a DEA registration and an MCSR.

Physicians and the corporate practice of medicine

Massachusetts follows the corporate practice of medicine doctrine. It rests on older case law and on the Board of Registration in Medicine’s 2012 amendments to 243 CMR 2.00, which list the vehicles through which a physician may practice: a professional corporation under M.G.L. c.156A, a nonprofit, a limited liability company or partnership, or a similar out-of-state organization. A general business corporation is not on the list. The usual structure is a physician-owned professional entity that delivers care and collects the fees, plus a separately owned management services organization (MSO) supplying marketing, technology, staff and billing under a fair-market-value management agreement; the Board’s fee-splitting rule and the anti-kickback statutes shape the management fee, so counsel drafts it.

So who may own the practice?

A physician may own the clinical entity outright. An NP with independent authority may generally own and operate a nursing practice; an NP still inside the two-year window can form the business but should have counsel confirm how the supervised-prescribing guidelines sit alongside ownership. A PA is the hard case: nothing found in the statute authorizes a PA to own a medical practice, so the usual answer is a physician- or NP-owned clinical entity with the PA as employee or MSO participant. Non-clinician spouses, partners and investors belong in the MSO.

Massachusetts telehealth rules for a remote hormone practice

Licensure and patient location. The Board of Registration in Medicine’s telemedicine policy (Policy 2020-01, adopted permanently in June 2020 and amended in February and October 2022) deems a physician to be practicing medicine in Massachusetts when the patient is physically located there, so a Massachusetts license is required. There is no out-of-state telehealth registration. Massachusetts has not joined the Interstate Medical Licensure Compact as of this writing, though bills are pending and a Telehealth Task Force reported to the legislature in mid-2026. The Nurse Licensure Compact was enacted in late 2024 but is not operational (implementation is targeted for 2027) and covers the RN license only; an APRN treating Massachusetts patients applies to the Board of Registration in Nursing for Massachusetts APRN authorization. The Nursing Board has published no telehealth-specific advisory ruling these notes could find, so treat patient location as controlling and confirm with the Board.

Establishing the relationship. Chapter 260 of the Acts of 2020 is mostly a coverage-and-payment law, but it gave Massachusetts a broad statutory definition of telehealth (M.G.L. c.112 §5O) covering synchronous audio-video, audio-only and asynchronous technologies, and it imposed no in-person-first rule. The Board of Registration in Medicine’s policy is explicit that the Board maintains no stand-alone requirement for a face-to-face encounter before telemedicine care, that the standard of care is identical to in-person care, and that physicians must still follow any state or federal law that does require an in-person evaluation. Massachusetts has no telemedicine-specific informed-consent statute; general consent duties under 243 CMR 2.07 and common law apply, so a documented telehealth consent covering modality, limitations, privacy and the right to in-person care is the practical standard. Verify identity and location at every visit.

Controlled substances and registrations. Testosterone is Schedule III, so every prescriber needs a DEA registration with a Massachusetts practice address and an MCSR from the Drug Control Program under M.G.L. c.94C §7 and 105 CMR 700.004. The two registrations must cover the same schedules; a prescriber who only prescribes needs a single MCSR usable at multiple locations. Massachusetts also schedules every other prescription drug as “Schedule VI,” so even non-controlled hormone products sit inside the state’s prescribing rules. Federal telemedicine rules for controlled substances have been revised several times; confirm the current federal position on in-person evaluation before the first testosterone prescription, and note that MassHealth imposes its own in-person requirement for Schedule II drugs under that program.

MassPAT and e-prescribing. M.G.L. c.94C §24A requires prescribers to check the Massachusetts Prescription Awareness Tool (MassPAT) each time they prescribe a Schedule II or III opioid or a benzodiazepine, and before first prescribing a Schedule IV or V drug the Department has designated as commonly misused. Testosterone is not on that mandatory list as commonly read, but a MassPAT check on every controlled prescription is sound practice. Separately, the 2018 CARE Act (Chapter 208 of the Acts of 2018) made electronic prescribing mandatory for essentially all prescription drugs and devices effective January 1, 2021, under 105 CMR 721.000, with exceptions for compounded preparations and a waiver process; an EHR with certified EPCS is non-negotiable.

See the full 12-week program →

Entity options, registered agent and Massachusetts taxes

Massachusetts has no separately named “PLLC”; instead, an LLC formed under M.G.L. c.156C may render professional services if the certificate of organization is accompanied by a certificate from the relevant licensing board that each member or manager who will render the service is licensed, and c.156C §65 requires professional liability insurance at minimums set by regulation. Physicians may alternatively form a professional corporation under c.156A, which lists physicians among the covered professions and requires every shareholder to be licensed to render its services. Nurses are covered by the LLC route and possibly the PC route; confirm with the Board of Registration in Nursing and counsel before choosing. Any MSO is an ordinary LLC or corporation. Every entity needs a registered agent with a physical Massachusetts street address.

Typical state costs, to confirm with the Secretary of the Commonwealth’s fee schedule and a Massachusetts CPA: an LLC files a $500 certificate of organization and a $500 annual report on the formation anniversary; a corporation files for $275 with a $125 annual report. Pass-through entities owe no entity-level excise; owners pay Massachusetts personal income tax at a flat 5 percent, with a 4 percent surtax on income above about $1.1 million for 2026. An entity taxed as a corporation owes the corporate excise, which carries a $456 minimum.

Labs and pharmacy in Massachusetts

Massachusetts is one of the handful of states where the national laboratories do not offer consumer-initiated testing. The clinical laboratory regulation at 105 CMR 180.280 lets a laboratory examine specimens only at the written request of a licensed physician, nurse practitioner, physician assistant or other authorized person, and 180.290 sends the report back to that ordering practitioner. For a cash-pay hormone practice this is a feature rather than a barrier: the clinic opens its own laboratory account, orders panels under the practitioner’s name, the patient walks into a Massachusetts draw site, and results return to the EHR. What does not work in Massachusetts is a “patient buys the test online, then books a visit” funnel; build intake so the practitioner’s order comes first, and keep lab relationships at arm’s length given the state’s self-referral rules (M.G.L. c.111D §8A).

On the pharmacy side, Massachusetts adopted nonresident pharmacy licensure in December 2024 (247 CMR 6.09). Any out-of-state pharmacy shipping prescription drugs to Massachusetts patients must hold a Massachusetts nonresident drug store license, and one that ships sterile compounded preparations, which includes injectable testosterone, or complex non-sterile compounds needs additional approval for that activity; enforcement against unlicensed shippers began May 1, 2025. Ask any compounding pharmacy for its Massachusetts nonresident license and compounding approval before routing the first prescription, keep a Massachusetts-licensed 503A compounder as a backup, and confirm how each pharmacy wants compounded orders transmitted given the e-prescribing exception.

Massachusetts at a glance

The 12-week Clinic In A Box map applied to Massachusetts

Clinic In A Box™ is a private, 1-on-1, done-with-you 12-week build led by an operator-mentor who runs active telemedicine clinics in the US, Colombia and Australia. The Massachusetts items land in the weeks shown.

• Weeks 1–4, Foundation. Niche and patient avatar; ownership model (physician-owned PC or LLC, NP-owned LLC, or clinical entity plus MSO) settled with counsel; entity filed with the board’s licensure certificate, registered agent named, liability coverage bound; Massachusetts license or APRN authorization confirmed and any multi-state pathway started; qualified healthcare professional and written guidelines in place for an NP inside the two-year window, or supervising physician and prescribing guidelines for a PA; DEA registration and MCSR applied for together with matching schedules; NPI; HIPAA framework, BAAs, and an EHR with certified EPCS, MassPAT integration and telehealth consent language.
• Weeks 5–8, Operations. Intake and telehealth consent built to Board Policy 2020-01 with identity and location verification at every visit; MassPAT check and any 96-hour Schedule II review wired into the prescribing workflow; lab account opened under the practitioner’s name and Massachusetts draw sites mapped, with the order sequenced before the draw; compounding pharmacies vetted for Massachusetts nonresident licensure and sterile-compounding approval; cash-pay service menu, subscription option and payment processing live.
• Weeks 9–12, Launch. Patient acquisition across Greater Boston, Worcester, the South Coast, the Cape and the western counties (Google Business where eligible, referrals, organic search); soft launch and first patients seen; revenue and retention tracking; a 90-day roadmap including the annual report date, the NP’s application for unsupervised prescribing when the two years are up, and the annual PA guideline review.

By week 12 the practice has a compliant Massachusetts entity, the right registrations, a configured EHR, lab and pharmacy relationships, a priced service menu and first patients. Read the telemedicine hormone clinic compliance guide for the national layer under these Massachusetts rules, and how to start a telemedicine hormone clinic for the full sequence. Massachusetts NPs can start with the nurse practitioner practice startup program page; physicians should read the physician telemedicine practice launch program page. The investment is $10,000 for two hours a week of direct work plus messaging between sessions; details are on the Clinic In A Box™ program page.

Frequently asked questions

Can a nurse practitioner open a telemedicine hormone clinic in Massachusetts without a physician?

Yes, once the NP has completed at least two years of supervised prescribing after certification (or qualifying alternative experience the Board accepts) and has been authorized by the Board of Registration in Nursing to prescribe without supervision. An NP still inside the two-year window can form the business and see patients but prescribes under written guidelines with a qualified healthcare professional, who may be a physician or an experienced APRN in the same category. Confirm the current 244 CMR 4.00 with the Board.

Does Massachusetts require an in-person visit before prescribing testosterone by telemedicine?

The Board of Registration in Medicine’s telemedicine policy states that the Board maintains no stand-alone face-to-face requirement before telemedicine care, as long as the standard of care is met. Testosterone is a federally controlled Schedule III drug, so federal telemedicine prescribing rules also apply and have changed several times; confirm the current federal position, and note MassHealth’s own in-person rules for Schedule II drugs.

Do I need a Massachusetts controlled-substance registration in addition to my DEA number?

Yes. Massachusetts requires a Massachusetts Controlled Substances Registration (MCSR) from the Department of Public Health’s Drug Control Program for anyone who prescribes Schedule II through VI drugs, with schedules matching the DEA registration. A prescriber who does not store or dispense needs a single MCSR usable at multiple locations. Confirm current fees and timelines with the Drug Control Program.

Can I treat Massachusetts patients from another state?

Only with a Massachusetts license, because the Board treats the patient’s physical location as the place of practice and there is no telehealth registration for out-of-state practitioners. Massachusetts has not adopted the Interstate Medical Licensure Compact as of 2026, though legislation is pending, and the Nurse Licensure Compact is not yet operational and covers the RN license only. Physicians apply to the Board of Registration in Medicine; APRNs apply to the Board of Registration in Nursing and then obtain an MCSR.

Request your free info session

The next step is a free 30-minute info session covering your credential, your Massachusetts licensing and supervision situation, your timeline and whether this is the right vehicle. Either way you leave with a clearer picture of what to do next. Call 844-734-2112 or use the form below.